Information for "A singular antiviral lncRNA EDAL shields any T309 OGlcNAcylation web site in promoting EZH2 lysosomal degradation"
From EECH Central
Basic information
Display title | A singular antiviral lncRNA EDAL shields any T309 OGlcNAcylation web site in promoting EZH2 lysosomal degradation |
Default sort key | A singular antiviral lncRNA EDAL shields any T309 OGlcNAcylation web site in promoting EZH2 lysosomal degradation |
Page length (in bytes) | 3,443 |
Page ID | 1439640 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Beretviola6 (Talk | contribs) |
Date of page creation | 07:45, 5 May 2024 |
Latest editor | Beretviola6 (Talk | contribs) |
Date of latest edit | 07:45, 5 May 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |